Urokinase Receptor Regulates Adhesion of Progenitor Cardiac Cells to Vitronectin


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Vitronectin, extracellular matrix protein, plays an important role in embryonic development and in organ and tissue reparation. A unique characteristic of vitronectin is specific binding of various biological molecules, including urokinase receptor (uPAR), extracellular matrix components, adhesion receptors, growth factors, thus supporting the modulation of cell behavior. Vitronectin is in fact not found in intact myocardium, while after infarction its level increases significantly, which correlates with accumulation of uPAR+ progenitor cardiac cells in the focus. The cells isolated from the heart of wild type mice are characterized by higher adhesion to vitronectin than progenitor cardiac cells from the myocardium of uPAR knockout mice. In addition, inhibition of urokinase receptor with specific antibodies on the surface of the progenitor cardiac cells of wild type mice leads to attenuation of their adhesive activity and flattening on vitronectin matrix, which can be important for their distribution in the postinfarction myocardium and realization of the reparative functions.

Sobre autores

K. Dergilev

Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation

Autor responsável pela correspondência
Email: doctorkote@gmail.com
Rússia, Moscow

Z. Tsokolaeva

Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation

Email: doctorkote@gmail.com
Rússia, Moscow

I. Beloglazova

Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation

Email: doctorkote@gmail.com
Rússia, Moscow

E. Zubkova

Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation

Email: doctorkote@gmail.com
Rússia, Moscow

E. Ratner

Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation

Email: doctorkote@gmail.com
Rússia, Moscow

Yu. Molokotina

Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation

Email: doctorkote@gmail.com
Rússia, Moscow

E. Parfenova

Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation; Laboratory of Postgenomic Technologies in Medicine, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University

Email: doctorkote@gmail.com
Rússia, Moscow; Moscow


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2019

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies